University of California, San Francisco: Prostatic Neoplasms trials
The registry lists 55 Prostatic Neoplasms studies with University of California, San Francisco as lead sponsor. 9 are open to participants now and 16 have results posted.
Early Phase 1 1Phase 1 7Phase 2 18Phase 3 1No phase 30(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- Cancer Oriented Understanding and Navigation Via Supportive and Educational Language Models (COUNSEL)Not yet recruitingNCT07836933Not applicable
- Social, Structural, and Lifestyle Drivers of Prostate Cancer DisparitiesRecruitingNCT07690579
- 177Lu-PSMA-617 With Liver Directed Therapy in Metastatic Castration Resistant Prostate CancerRecruitingNCT07145177Phase 1
- Tumor Genomic Pre-test Counseling Tool for Black or African-American Men With Prostate CancerRecruitingNCT06171139Not applicable
- Pembrolizumab Plus 177Lu-PSMA-617 in Patients With Castration Resistant Prostate CancerRecruitingNCT05766371Phase 2
- Mechanisms of Resistance to PSMA Radioligand TherapyRecruitingNCT05435495
- Patient Decision-making About Precision Oncology in Veterans With Advanced Prostate CancerRecruitingNCT05396872Not applicable
- Community-Based Health Coach for Access to Germline Genetic Testing Among African American Men With Prostate CancerRecruitingNCT04763980Not applicable
- Hyperpolarized Pyruvate (13C) MR Imaging in Monitoring Patients With Prostate Cancer on Active SurveillanceRecruitingNCT03933670Phase 2
- 177Lu-PSMA-617 and Pembrolizumab in Treating Patients With Metastatic Castration-Resistant Prostate CancerCompletedNCT03805594Phase 1Results posted
- Pembrolizumab in Metastatic Castration Resistant Prostate Cancer (mCRPC) With or Without DNA Damage Repair DefectsCompletedNCT03248570Phase 2Results posted
- Gallium-68 PSMA-11 PET in Intermediate to High-risk Preprostatectomy PatientsCompletedNCT02919111Phase 2/3Results posted
- Trial of Radiotherapy With Leuprolide and Enzalutamide in High Risk Prostate CancerTerminatedNCT02508636Phase 2Results posted
- 11C- and 18F-Choline PET/MR Imaging for Prostate CancerCompletedNCT02397408Phase 2Results posted
- Selinexor in Treating Patients With Abiraterone Acetate and/or Enzalutamide Refractory Metastatic Castration-Resistant Prostate CancerTerminatedNCT02215161Phase 2Results posted
- Sipuleucel-T With Immediate vs. Delayed Cytotoxic T-Lymphocyte-Associated Protein 4 (CTLA-4) Blockade for Prostate CancerCompletedNCT01804465Phase 2Results posted
- Itraconazole in Treating Patients With Biochemically Relapsed Prostate CancerCompletedNCT01787331Phase 2Results posted
- Abiraterone Post Ketoconazole for Prostate CancerCompletedNCT01199146Phase 2Results posted
- Ketoconazole and Dexamethasone in Prostate CancerCompletedNCT01036594Phase 2Results posted
- Feasibility of Using SPECT/CT Imaging to Map Lymphatic Drainage Patterns in Prostate Cancer PatientsCompletedNCT01008969Not applicableResults posted
- MRI and Magnetic Resonance Spectroscopy Imaging in Patients Receiving Dutasteride for Benign Prostatic Hypertrophy and Low-Risk Prostate CancerCompletedNCT00706966Not applicableResults posted
- Pharmacokinetic and Efficacy Study of Nordihydroguaiaretic Acid (NDGA) in Non Metastatic Recurrent Prostate CancerTerminatedNCT00678015Phase 2Results posted
- Sandostatin for Patients With Androgen Independent Prostate CancerTerminatedNCT00510224Phase 2Results posted
- Intermittent Chemotherapy With or Without Granulocyte-macrophage Colony-stimulating Factor (GM-CSF) for Metastatic Hormone Refractory Prostate Cancer (HRPC)CompletedNCT00488982Phase 2Results posted
- Lycopene or Omega-3 Fatty Acid Nutritional Supplements in Treating Patients With Stage I or Stage II Prostate CancerCompletedNCT00402285Not applicableResults posted
- Efficacy of Ra-223 in PSMA PET Optimally Selected PatientsActive, not recruitingNCT05924672Phase 2
- Predicting Cognitive Decline From Androgen Deprivation TherapyTerminatedNCT05820932
- Leveraging Technology to Achieve Equity for Men With Prostate Cancer on Androgen Deprivation TherapyCompletedNCT05324098Not applicable
- MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate CancerCompletedNCT05127850Not applicable
- Improving Nutrition and Physical Activity for Cancer Survivors (Tools To Be Fit)Active, not recruitingNCT05056077Not applicable
- mHealth ElectroNic COnsultation REcording (mENCORE) in Advanced Prostate CancerCompletedNCT04545697Not applicable
- Expanded Access 68Gallium-PSMA-11 PET for Prostate CancerApproved for marketingNCT04377152
- Diet and Exercise Interventions Among Men With Prostate Cancer (Prostate 8-II)Active, not recruitingNCT03999151Not applicable
- An Electronic Registry to Improve Adherence to Active Surveillance Monitoring at a Safety-net HospitalTerminatedNCT03553732
- Pioneering Advances in Care and Education (PACE)CompletedNCT03397160Not applicable
- PROMOTE: Identifying Predictive Markers of Response for Genitourinary CancerActive, not recruitingNCT02735252Not applicable
- CHAMP: A Randomized Controlled Trial of High-intensity Aerobic and Resistance Exercise for Metastatic Prostate CancerCompletedNCT02613273Not applicable
- Web-based Lifestyle Trial Among Men With Prostate Cancer: Prostate 8CompletedNCT02470936Not applicable
- Decision Support Tools for Men With Prostate Cancer- Clinical & Lifestyle ModelCompletedNCT02451345Not applicable
- MRI With C13 Pilot Study Prostate CancerTerminatedNCT02450201Early Phase 1
- Active Surveillance Exercise Clinical TrialCompletedNCT02435472Not applicable
- Radiologically Guided Biopsies of mCRPCCompletedNCT02432001
- A Study of Intra-operative Autologous Retropubic Urethral Sling on Urinary Control After Robot Assisted Radical ProstatectomyCompletedNCT01821209Not applicable
- Hyperpolarized Pyruvate Injection in Subjects With Prostate CancerCompletedNCT01229618Phase 1
- Phase I Targeting Dominant Intraprostatic Lesion Using MR Spectroscopy and HDR BrachytherapyCompletedNCT00807820
- Predicting the Risk of Failure in Patients Undergoing Radiation Therapy for Localized Prostate CancerActive, not recruitingNCT00769223
- Nutrition and Lifestyle Changes in Patients With Previously Untreated Stage I or Stage II Prostate CancerCompletedNCT00739791Not applicable
- Frequency of Prostate-Specific Antigen Screening in African American Men in the San Francisco AreaCompletedNCT00702104
- Study of Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) for Patients With Rising Prostate-Specific Antigen (PSA)CompletedNCT00678054Phase 2
- Effect of Androgen Blockade Therapy on Thymus Function in Older Patients Who Have Undergone Radical Prostatectomy for Localized Prostate CancerTerminatedNCT00379119
- Lapatinib and Paclitaxel in Treating Patients With Advanced Solid TumorsCompletedNCT00313599Phase 1
- Nordihydroguaiaretic Acid in Treating Patients With Nonmetastatic Relapsed Prostate CancerTerminatedNCT00313534Phase 1
- Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone TherapyCompletedNCT00309894Phase 2
- GM-CSF Before Surgery in Treating Patients With Localized Prostate CancerCompletedNCT00305669Phase 1
- Docetaxel, Prednisone, and Vatalanib in Treating Patients With Advanced Prostate CancerTerminatedNCT00293371Phase 1/2